Oramed to be Added to Russell Microcap® Index
NEW YORK, June 19, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc.(NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be added to the FTSE Russell Microcap® Index effective at the open of market on June 25, 2018, as part of the Russell Indexes […]
